Frost & Sullivan ranks cancer immunotherapy and high throughput gene sequencing among top 10 health and wellness enabling technologies
MOUNTAIN VIEW, California, Oct. 21, 2015 /PRNewswire/ -- Health and wellness technologies have the potential to enable the steady growth of novel diagnostic and therapeutic drugs capable of eliminating a plethora of chronic and acute diseases. With the convergence of predictive analytics and mined genetic data, diagnostic and therapeutic capabilities will improve significantly. By upgrading and ingraining the data analytics and genetic information into the healthcare system, accurate diagnostics will become a reality.
Analysis from Frost & Sullivan, Top Health and Wellness Technologies in 2015 (http://bit.ly/1W2trLY), finds high throughput gene sequencing (HTGS), antibody therapeutics, biomarkers, cancer immunotherapy, targeted drug delivery, regenerative medicine, point-of-care diagnostics, gene therapy, synthetic biology and molecular farming are the leading health and wellness technologies transforming healthcare.
For complimentary access to more information on this research, please visit: http://bit.ly/1LuLHdR.
In the rapidly growing cancer immunotherapy segment, there are close to 120 therapeutic solution developers working on breakthrough technologies to boost products for numerous types of cancer. These technologies are set to reduce the potential side effects people face with conventional treatment strategies.
"The high cost of cancer drugs has made it difficult for a large majority of the global population to access these medications, reasonable pricing of new drugs will be important," noted TechVision Senior Research Analyst Madhumitha Rangesa. "While this will increase the adoption of cancer immunotherapy and certain other life sciences technologies, the competitive landscape will pose challenges for market participants in these segments."
In the HTGS space, price is less of an issue as the cost of next-generation sequencers (NGS) has plummeted. Additionally, major developments to improve the accuracy and speed of devices as well as emerging business models for analyzing raw data output from NGS, will heighten the application potential of HTGS.
"As HTGS adoption rates increase due to the rising demand for personalized genomics and point-of-care diagnostics allowing on-the-spot sequencing, more investors will get involved, driving the entire industry forward," said Rangesa. "Furthermore, the development of customized diagnostics panels, exome sequencing, and whole genome sequencing will make a huge difference to the healthcare industry. Data produced through all of these platforms will create new markets in the bioinformatics space that could lead to extensive involvement with software companies."
Overall, trends across the 10 key technologies of 2015 are guiding the entire healthcare industry by positively impacting government legislation, global and regional healthcare expenditure and the operation of patient-centric care facilities.
Top Health and Wellness Technologies in 2015, a part of the Health & Wellness (http://ww2.frost.com/research/technology/health-wellness) subscription, identifies and profiles 10 technologies expected to shape the health and wellness industry. The list includes technologies that are already in the market as well as recently commercialized technologies. This research throws light on technology capability, maturity, global research intensity, adoption over the short and medium terms, and funding activities.
Frost & Sullivan's global TechVision practice is focused on innovation, disruption and convergence that provides a variety of technology based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision program, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision program is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth. View a summary of our TechVision program by clicking on the following link: http://ifrost.frost.com/TechVision_Demo.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Top Health and Wellness Technologies in 2015
Corporate Communications – North America
SOURCE Frost & Sullivan